A Comparative Study between C-Reactive Protein and Procalcitonin in Iraqi Burn Patients
DOI:
https://doi.org/10.23851/mjs.v28i1.310Keywords:
Procalcitonin, C-reactive protein, Biomarkers, Burned patients.Abstract
Association between Procalcitonin (PCT) and C-reactive protein (CRP) and burn injury was evaluated in 80 burned patients from Al-Kindy and Imam Ali hospitals in Baghdad-Iraq. Patients were divided into two groups, survivor group 56 (70%) and non-survivor group 24 (30%). PCT was estimated using (Human Procalcitonin ELISA kit) provided by RayBio/USA while CRP was performed using a latex agglutination kit from Chromatest (Spain). Our results declared that the mean of Total Body Surface Area (TBSA %) affected were 63.5% range (36%–95%) in non-survivor patients, while 26.5% range (10%–70%) in survivor patients. There is a significant difference between the two groups (P = 0.00), the higher mean percentage of TBSA has a significant association with mortality. Serum PCT and CRP were measured at the three times of sampling (within the first 48hr following admission, after 5thdays and after 10th days). The mean of PCT serum concentrations in non-survivor group (2638 ± 3013pg/ml) were higher than that of survivor group (588 ± 364pg/ml). Significantly high levels of CRP were found between the survivor and non-survivor groups especially in the 10th day of admission P=0.000, present study show that significant differences is found within the non-survivor group through the three times P= 0.01, while results were near to significant differences within survivor group through the three times (P= 0.05).Downloads
References
Rowan, M. P.; Cancio, L. C.; Elster, E. A.; Burmeister, D. M.; Rose, L. F.; Natesan, S.and Chung, K. K. Burn wound healing and treatment: review and advancements. Critical care, 2015. 19, 243. CrossRef
Barret, J. P.; Herndon, D.N. Effects of burn wound excision on bacterial colonization and invasion. Plast Reconstr Surg 2003; 111 (2): 744-50; discussion 751-752. CrossRef
McCulloh, R.J. Biomarkers in Sepsis and Severe Infection: Where Immunology Meets Diagnostics. 2012. J Immunodefic Disor 2012, 1: 1. CrossRef
Castelli, G.P.; Pognani, C.; Meisner, M.; Stuani, A., Bellomi, D. and Sgarbi, L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care. 2004 Aug; 8 (4): R234-42. CrossRef
Aabenhus, R.1; Jensen, J.U. Procalcitoninguided antibiotic treatment of respiratory tract infections in a primary care setting: are we there yet? Prim Care Respir J. 2011 Dec, 20 (4): 360-7. CrossRef
Caliendo, A. M.1; Gilbert, D.N.; Ginocchio, C. C.; Hanson, K.E.; May, L.; Quinn, T.C.; Tenover, F.C.; Alland, D.; Blaschke, A.J.; Bonomo R.A., Carroll, K.C.; Ferraro, M.J.; Hirschhorn, L.R.; Joseph, W.P.; Karchmer T.; MacIntyre, A.T.; Reller, L.B. and Jackson, A.F. Infectious Diseases Society of America (IDSA). Better tests, better care: improved diagnostics for infectious diseases. Clin Infect Dis. 2013 Dec;57 Suppl 3: S139-70. CrossRef
Mohan, A. and Harikrishna, J. Biomarkers for the diagnosis of bacterial infections: in pursuit of the 'Holy Grail'Indian J Med Res. 2015 Mar; 141 (3): 271–273. CrossRef
Mokline, A.; Garsallah, L.;Rahmani, I.; Jerbi, K.; Oueslati, H.; Tlaili, S.; Hammouda, R.; Gasri, B.and Messadi, A.A. Procalcitonin: a diagnostic and prognostic biomarker of sepsis in burned patients. Ann Burns Fire Disasters. 2015 Jun 30;28 (2): 116-20.
Rosanova, M. T.; Tramonti, N.; Taicz, M.; Martiren, S.; Basilico, H.; Signorelli, C.and Lede, R. Assessment of C-reactive protein and procalcitonin levels to predict infection and mortality in burn children. Arch Argent Pediatr, 2015. 113 (1), 36-41.
Kim, H. S.; Yang, H. T.; Hur, J.; Chun, W.; Ju, Y. S.; Shin, S. H.and Lee, K. M. Procalcitonin levels within 48 hours after burn injury as a prognostic factor. Ann Clin Lab Sci, 2012. 42 (1), 57-64.
Nakae, H.; Inaba, H.and Endo, S. Usefulness of procalcitonin in Pseudomonas burn wound sepsis model. Tohoku J Exp Med. 1999 Jul;188 (3): 271-3. CrossRef
Tahir, S1.; Memon, A.R.; Kumar, M.and Ali, S.A. Prediction of mortality after major burn: physiological versus biochemical measures. Wounds. 2009 Jul; 21 (7): 177-82.
Zarei, M.R.1; Dianat, S.; Eslami, V.; Harirchi, I.; Boddouhi, N.; Zandieh A. and Rasouli, M.R. Factors associated with mortality in adult hospitalized burn patients in Tehran. Ulus Travma Acil Cerrahi Derg, 2011. Jan;17 (1): 61-5.
Moore, E.C.; Pilcher, D.V.; Bailey, M.J.; Stephens, H.and Cleland, H. The Burns Evaluation and Mortality Study (BEAMS): predicting deaths in Australian and New Zealand burn patients admitted to intensive care with burns. Journal Trauma Acute Care Surg, 2013. Aug;75 (2): 298-303.
Zhao, D.; Zhou, J.; Haraguchi, G.; Arai, H. and Mitaka, C.Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac surgery. J Intensive Care, 2014. Jun 3;2: 35.
Klingele, M.; Bomberg, H.; Poppleton, A.; Minko, P.; Speer, T.; Schäfers, H.J. and Groesdonk, H.V.Elevated procalcitonin in patients after cardiac surgery: a hint to nonocclusive mesenteric ischemia. Ann Thorac Surg, 2015. Apr;99 (4): 1306-12.
Barati, M.; Alinejad, F.; Bahar, M. A.; Tabrisi, M. S.; Shamshiri, A. R.;Bodouhi, N.O.; and Karimi, H. Comparison of WBC, ESR, CRP and PCT serum levels in septic and non-septic burn cases. Burns, 2008. 34 (6), 770-774. CrossRef
Seoane, L.; Pertega, S.; Galeiras, R.; Astola, I.; and Bouza, T. Procalcitonin in the burn unit and the diagnosis of infection. Burns, 2014. 40 (2), 223-229. CrossRef
Mann, E. A.; Wood, G. L.; and Wade, C. E. Use of procalcitonin for the detection of sepsis in the critically ill burn patient: a systematic review of the literature. Burns, 2011. 37 (4), 549-558. CrossRef
Von Heimburg, D., Stieghorst, W., Khorram-Sefat, R. and Pallua, N. Procalcitonin—a sepsis parameter in severe burn injuries. Burns, 1998. 24 (8), 745-750 CrossRef
Neely, A. N.; Smith, W. L.; and Warden, G. D. Efficacy of a rise in C-reactive protein serum levels as an early indicator of sepsis in burned children. J Burn Care Rehabil, 1998. 19 (2), 102-105. CrossRef
Alkazaz F.F.; Abdulsattar S.A.; Farred F.A. and Mahmood S.J. Risk factor of metabolism alteration in burn patients. SENRA Academic Publishers, British Columbia, 2014.Vol. 8, No. 3, pp. 3057-3060,
Jeschke, M. G.; Finnerty, C. C.; Kulp, G. A.; Kraft, R.; and Herndon, D. N. Can we use C-reactive protein levels to predict severe infection or sepsis in severely burned patients? International Journal of Burns and Trauma, 2013. 3 (3), 137-143.
Lavrentieva, A.; Kontakiotis, T.; Lazaridis, L.; Tsotsolis, N.; Koumis, J.; Kyriazis, G.; and Bitzani, M. Inflammatory markers in patients with severe burn injury. What is the best indicator of sepsis? Burns, 2007. 33 (2), 189-194. CrossRef
Neely, A. N.; Fowler, L. A.; Kagan, R. J.; and Warden, G. D. Procalcitonin in pediatric burn patients: an early indicator of sepsis? Journal Burn Care Rehabil, 2004. 25 (1), 76-80. CrossRef
Sachse, C.; Machens, H. G.; Felmerer, G.; Berger, A.; and Henkel, E. Procalcitonin as a marker for the early diagnosis of severe infection after thermal injury. J Burn Care Rehabil, 1999. 20 (5), 354-360. CrossRef
Downloads
Key Dates
Published
Issue
Section
License
Articles accepted for publication in Al-Mustansiriyah Journal of Science (MJS) are protected under the Creative Commons Attribution 4.0 International License (CC BY-NC). Authors of accepted articles are requested to sign a copyright release form prior to their article being published. All authors must agree to the submission, sign copyright release forms, and agree to be included in any correspondence between MJS and the authors before submitting a work to MJS. For personal or educational use, permission is given without charge to print or create digital copies of all or portions of a MJS article. However, copies must not be produced or distributed for monetary gain. It is necessary to respect the copyright of any parts of this work that are not owned by MJS.
How to Cite
